MOLNUPIRAVIR belongs to a class of drugs called antiviral agents indicated for the mild to the moderate treatment of Covid-19. Coronavirus disease/Covid-19, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is an infectious disease caused by the coronavirus. Its symptoms include fever and cough and, in some cases, progressing to pneumonia and respiratory failure.
MOLNUPIRAVIR contains Molnupiravir, a protease inhibitor. It works by interfering with a protein known as protease, which is necessary for the virus-infected cells to generate new viruses. As a result, the resulting virus particles have faulty genetic material and can no longer reproduce. Thereby, MOLNUPIRAVIR lowers virus load in the body and helps treat the infection.
Take MOLNUPIRAVIR as prescribed. To treat your condition effectively, you are advised to take MOLNUPIRAVIR for as long as your doctor has prescribed it. In some cases, MOLNUPIRAVIR may cause nausea, vomiting, diarrhoea, headache, and dizziness. Most of these side effects do not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, please consult a doctor.
Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking MOLNUPIRAVIR if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. MOLNUPIRAVIR may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with MOLNUPIRAVIR is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your healthcare professional updated on your medical condition and medications to rule out any interactions.
Covid-19 or Coronavirus.
MOLNUPIRAVIR is an experimental antiviral medication that lowers the risk of hospitalisation or death in patients with mild or moderate covid-19. MOLNUPIRAVIR is a potent protease inhibitor that interferes with a protein (protease) required by virus-infected cells to generate new viruses. As a result, MOLNUPIRAVIR helps reduce viral load in the body and aids in infection therapy.
Please do not take MOLNUPIRAVIR if you are allergic to any of its ingredients. Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking MOLNUPIRAVIR if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. MOLNUPIRAVIR may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with MOLNUPIRAVIR is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your doctor updated on your medical condition and medications to rule out any interactions.
Drug-Drug Interactions: No interactions were found/established.
Drug-Food Interactions: No interactions were found/established.
Drug-Disease Interactions: No interactions were found/established.
It is unknown whether it is safe to consume alcohol with MOLNUPIRAVIR. However, it is advisable not to take or limit alcohol as it may lead to increased dizziness.
MOLNUPIRAVIR is not recommended for use during pregnancy. Please seek medical advice if you are pregnant or intend to get pregnant. Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose.
MOLNUPIRAVIR is not recommended during breastfeeding. Breastfeeding should be discontinued during the treatment and for 4days after the last dose.
MOLNUPIRAVIR may cause dizziness. So, drive only if you are alert.
Limited information is available regarding the usage of MOLNUPIRAVIR in patients suffering from liver impairment. Please consult your doctor if you have any concerns.
Limited information is available regarding the usage of MOLNUPIRAVIR in patients suffering from kidney impairment. Please consult your doctor if you have any concerns.
The safety and effectiveness of MOLNUPIRAVIR have not been established in children below 18years. Please consult your doctor if you have any concerns.
COVID-19: COVID-19 disease is an infectious disease caused by a coronavirus. It is also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2). Coronavirus belongs to the RNA virus family and contains crown-like projections on its surface. The virus spreads through droplets produced by an infected person's cough, sneeze, or heavy breathing. Coronavirus sickness is characterised by dry cough, dyspnea, shortness of breath, fever, loss of taste and smell, diarrhoea, body pains, headache, and sore throat.